Jeffrey Gudin
2021
In 2021, Jeffrey Gudin earned a total compensation of $303K as Executive VP, Chief Medical Officer at Virpax Pharmaceuticals, a 75% increase compared to previous year.
Compensation breakdown
| Bonus | $45,000 |
|---|---|
| Option Awards | $158,000 |
| Salary | $100,000 |
| Total | $303,000 |
Gudin received $158K in option awards, accounting for 52% of the total pay in 2021.
Gudin also received $45K in bonus and $100K in salary.
Rankings
In 2021, Jeffrey Gudin's compensation ranked 11,597th out of 12,415 executives tracked by ExecPay. In other words, Gudin earned more than 6.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,597 out of 12,415 | 7th |
Division Manufacturing | 5,104 out of 5,505 | 7th |
Major group Chemicals And Allied Products | 2,253 out of 2,375 | 5th |
Industry group Drugs | 2,000 out of 2,096 | 5th |
Industry Pharmaceutical Preparations | 1,479 out of 1,546 | 4th |
Source: SEC filing on June 15, 2022.
Gudin's colleagues
We found two more compensation records of executives who worked with Jeffrey Gudin at Virpax Pharmaceuticals in 2021.